Through care, support, education, and research, the Rocky Mountain MS Center is leading the way in developing effective treatments and therapies. The Rocky Mountain MS Center is a local nonprofit…
Read More
An Interview with Dr. Timothly Vollmer InforMS: Many advancements and research in MS are really leading to neuro-reparative therapy. Can you tell us what’s changed to spur that? Dr. Vollmer: I…
The Translational Research Lab has presented the RMMSC at CU with unique opportunities for collaborations with other medical groups, both inside and outside the CU community. “We are collaborating with…
Research efforts at the Rocky Mountain MS Center at University of Colorado have been at the forefront of multiple sclerosis care and treatment for decades, but in all those years…
The DISCO-MS trial looked at the question “Can we define a population of patients in whom it’s safe to discontinue their disease modifying therapy (DMT) for MS as they age?”…
Dr. Timothy Vollmer hosts an informal discussion of the state of MS research today. Recorded on May 19, 2022. Dr. Vollmer talks about remyelination prospects, treatments for progressive MS, neurofilament…
One of the problems faced by some people with multiple sclerosis who are working is the need for frequent absences. The increased need for absences among people with MS is…
An Interview with Christy Dittmar, MS, OTR/L, CDRS. As we’ve discussed throughout this issue, fatigue is an extremely common, complex, and challenging problem in MS. Frustratingly, there is no one…
Fatigue is not only one of the most common MS symptoms, it’s also one of the most frustrating for people to manage. In this issue, we’re presenting an update to…
